Description

Wolverine TB/BPC Stack

Overview

The Wolverine Stack is a powerful regenerative blend of two synergistic peptides—BPC-157 and TB-500—engineered for athletes, biohackers, and high-performance individuals seeking accelerated recovery, reduced inflammation, and enhanced tissue repair. The stack gets its nickname from its potent ability to regenerate tissue similarly to how Wolverine heals in comic lore—fast, deep, and thorough.

BPC-157 (Body Protection Compound)

BPC-157 is a 15-amino acid peptide derived from a protein found in the human stomach. It has demonstrated remarkable regenerative properties in soft tissue, tendons, ligaments, and the digestive tract. Known for its ability to upregulate growth factors and modulate nitric oxide, BPC-157 supports rapid healing and inflammation reduction at the injury site. It is especially favored in musculoskeletal and gut-related recovery protocols.

TB-500 (Thymosin Beta-4)

TB-500 is a synthetic version of a naturally occurring peptide that plays a key role in cellular migration, angiogenesis, and inflammation modulation. TB-500 supports muscle regeneration, cardiac tissue repair, and recovery from overtraining. It functions by regulating actin, a critical component of cell structure and movement, allowing cells to travel efficiently to damaged areas and accelerate healing.

Stacking Rationale

Stacking BPC-157 with TB-500 combines localized healing (BPC-157) with systemic regeneration (TB-500). While BPC-157 targets the direct site of injury and reduces inflammation rapidly, TB-500 enhances blood flow and healing throughout the body. This dual-action synergy has made the Wolverine Stack a go-to protocol in regenerative therapy, sports medicine, and advanced recovery programs.

Potential Benefits

• Rapid repair of tendons, ligaments, and muscle tears • Reduction of chronic inflammation and joint pain • Accelerated post-surgical recovery • Enhanced angiogenesis (blood vessel formation) • Gut lining restoration and neuroprotective effects • Increased flexibility and reduced scar tissue

Common Dosing Protocol

• BPC-157: 250–500mcg daily (subcutaneous near injury or systemic use) • TB-500: 2–5mg weekly (split into 2 injections) for initial loading phase (4–6 weeks) • Maintenance: 2–3mg every 2 weeks after loading Always rotate injection sites and use under guidance of a healthcare professional.